Valiant Navion™ VNMF4646C183TU (UDI 00763000100803)Recalls & reported problems
Medtronic, Inc. · STENT GRAFT VNMF4646C183TU VAL NAV FF · Class 3 · Implant
All models of Valiant Navion (137)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 4
- Deaths reported
- 2
- Injuries reported
- 2
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00763000100803), received between Feb 17, 2023 and May 2, 2025 — classified as 2 deaths, 2 injuries.
The most frequently reported specific device problem is “Leak/Splash” (4 reports).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- Feb 12, 2021Class IOpen, Classified
Due to the presence of type IIIb endoleaks, stent fractures, and stent ring enlargement.
Z-1201-2021 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Most reported problems
Device problems
- Leak/Splash4
- Adverse Event Without Identified Device or Use Problem3
- Detachment of Device or Device Component1
- Fracture1
Patient problems
- Insufficient Information3
- Pain1
- Rupture1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryMay 2, 2025Fracture; Leak/Splash; Adverse Event Without Identified Device or Use Problem; Fracture; Leak/Splash; Adverse Event Without Identified Device or Use Problem
VALIANT NAVION STENT GRAFTS WERE IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A 59MM TAAA. THE 43X43X100 WAS IMPLANTED PROXIMALLY, 46X46X183 DISTALLY, BRIDGED WITH 46X46X183 STENT GRAFT. THE PATIENT WAS LOST TO FOLLOW-UP AND LATER PRESENTED TO A DIFFERENT FACILITY FOR AN UNRELATED INCIDENT AND A CT SCAN WAS PERFORMED . ON THE CT SCAN, THE TWO PHYSICIANS REVIEWING INITIALLY THOUGHT THAT THE DISTAL AND MIDDLE NAVION DEVICES HAD PULLED UP FROM THEIR INITIAL LANDING ZONES DUE TO ANEURYSM ENLARGEMENT BUT A STENT FRACTURE WAS ALSO SUGGESTED AS POSSIBLE CAUSE OF THE ISSUE. A PLAN WAS MADE TO RELINE THE DEVICE DOWN TO THE SMA AS THE CELIAC ARTERY WAS COMPLETELY STENOSED WITHOUT ANTEGRADE FLOW, THE STENOSIS WAS UNRELATED TO THE NAVION STENT GRAFTS. NO ISSUES WERE NOTED WITH THE OTHER STENT GRAFTS. DURING THE INTERVENTION PROCEDURE, A FRACTURE PIECE OF THE STENT COULD BE VISUALIZED WELL BELOW THE REMAINING FABRIC AND STENT BODY OF THE MOST DISTAL NAVION DEVICE. THE PHYSICIAN THEN SUSPECTED THAT THE DISTAL NAVION FRACTURED LEAVING BEHIND A PARTIAL STRUT IN THE INITIAL DISTAL LANDING ZONE, WITH ITS FABRIC AND REMAINING STRUTS PULLED UP TOWARDS THE AORTIC ARCH. THE VALIANT NAVION LOST DISTAL SEAL
Patient problems: Insufficient Information
MAUDE report 21949430 ↗DeathAug 14, 2023Leak/Splash; Detachment of Device or Device Component; Adverse Event Without Identified Device or Use Problem; Leak/Splash; Detachment of Device or Device Component; Adverse Event Without Identified Device or Use Problem
VALIANT NAVION STENT GRAFTS WERE IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A THORACIC ANEURYSM ON AN UNKNOWN DATE. 2 VALIANT CAPTIVIA STENT GRAFTS WERE ALSO IMPLANTED. IT WAS REPORTED CORE LAB REVIEW OF CT IMAGING ON (B)(6) 2018, ON (B)(6) 2019, ON (B)(6) 2020 AND ON (B)(6) 2021. THE CT REVIEW OF IMAGES FROM ON (B)(6) 2018 REVEALED A TYPE IA ENDOLEAK ON VNMF4646C183TU (B)(6). IMAGES FROM ON (B)(6) 2019, REVEALED TYPE IA ENDOLEAK AND AORTIC ENLARGEMENT OF +13.6MM WITH APPARENT AORTIC RUPTURE. THE FOLLOWING OBSERVATIONS WERE ALSO MADE; ON (B)(6) 2019, REVEALED AORTIC ENLARGEMENT OF 11.4MM. ON (B)(6) 2019, CT IMAGES REVEALED 12 MM AORTIC ENLARGEMENT. ON (B)(6) 2019, IMAGING SHOWED AORTIC ENLARGEMENT 12 MM. ON (B)(6) 2019, IMAGES REVEALED 13.3 MM AORTIC ENLARGEMENT. ON (B)(6) 2019, REVEALED 14.8 MM AORTIC ENLARGEMENT. ON (B)(6) 2020, REVEALED STENT RING ENLARGEMENT (SRE) +1.5MM (NEW), RING 2; VNMF4646C183TU (B)(6) AND AORTIC ENLARGEMENT 17.6 MM. SRE IS IN THE FIRST SEALING STENT OF THE MOST PROXIMAL DEVICE (VNMF4646C183TU (B)(6). ON (B)(6) 2021, REVEALED TYPE IA ENDOLEAK (VNMF4646C183TU (B)(6), AND SRE 1.4MM ON RING 2 OF VNMF4646C183TU (B)(6) AND AORTIC ENLARGEMENT OF 23.3MM, SR
Patient problems: Insufficient Information; Rupture
MAUDE report 17539157 ↗InjuryMay 3, 2023Leak/Splash; Leak/Splash
VALIANT NAVION STENT GRAFTS WERE IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC DISSECTION. IT WAS REPORTED 3 DAYS POST THE INDEX PROCEDURE, THE PATIENT WAS COMPLAINING OF BACK PAIN. CT IDENTIFIED TYPE IA AND TYPE IB ENDOLEAKS NOTED AS MINOR ENDOLEAKS. INTERVENTION WAS COMPLETED WITH COILING OF THE FALSE LUMEN PERFORMED TO RESOLVE THE ENDOLEAKS. PER THE PHYSICIAN THE CAUSE OF THE ENDOLEAKS ARE UNDETERMINED. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.
Patient problems: Pain
MAUDE report 16858995 ↗DeathFeb 17, 2023Leak/Splash; Adverse Event Without Identified Device or Use Problem; Leak/Splash; Adverse Event Without Identified Device or Use Problem
A VALIANT NAVION STENT GRAFT WAS IMPLANTED IN THE ENDOVASCULAR TREATMENT IT WAS REPORTED CT IMAGING TAKEN UNDER THREE YEARS LATER IDENTIFIED A TYPE IA ENDOLEAK ON THE STENT GRAFT WITH SN (B)(4). THE MAXIMUM AORTIC DIAMETER WAS 71.7MM. NO STENT RING ENLARGEMENT OR MIGRATION WERE NOTED. NE FOR FRACTUES DUE TO DEVICE OVERLAPS. THE PATIENT DIED UNDER A MONTH DUE TO AN UNKNOWN CAUSE. THERE IS NO DEATH CERTIFICATE AVAILABLE. PER THE PHYSICIAN THE CAUSE OF THE ENDOLEAK COULD NOT BE DETERMINED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT IS EXPIRED.
Patient problems: Insufficient Information
MAUDE report 16395078 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page